These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 30077775)

  • 1. Oligodendrogliopathy in neurodegenerative diseases with abnormal protein aggregates: The forgotten partner.
    Ferrer I
    Prog Neurobiol; 2018 Oct; 169():24-54. PubMed ID: 30077775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diversity of astroglial responses across human neurodegenerative disorders and brain aging.
    Ferrer I
    Brain Pathol; 2017 Sep; 27(5):645-674. PubMed ID: 28804999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oligodendroglia and Myelin in Neurodegenerative Diseases: More Than Just Bystanders?
    Ettle B; Schlachetzki JCM; Winkler J
    Mol Neurobiol; 2016 Jul; 53(5):3046-3062. PubMed ID: 25966971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cellular pathology of neurodegenerative disorders].
    Wakabayashi K
    Rinsho Shinkeigaku; 2013; 53(8):609-17. PubMed ID: 23965852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropathological spectrum of synucleinopathies.
    Jellinger KA
    Mov Disord; 2003 Sep; 18 Suppl 6():S2-12. PubMed ID: 14502650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic and Transcriptomic Profiles of Inflammation in Neurodegenerative Diseases: Alzheimer, Parkinson, Creutzfeldt-Jakob and Tauopathies.
    López González I; Garcia-Esparcia P; Llorens F; Ferrer I
    Int J Mol Sci; 2016 Feb; 17(2):206. PubMed ID: 26861289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein aggregate formation in oligodendrocytes: tau and the cytoskeleton at the intersection of neuroprotection and neurodegeneration.
    Richter-Landsberg C
    Biol Chem; 2016 Mar; 397(3):185-94. PubMed ID: 26083267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pathology of basal ganglia in neurodegenerative diseases].
    Wakabayashi K; Tanji K; Mori F
    Brain Nerve; 2009 Apr; 61(4):429-39. PubMed ID: 19378813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An emerging role of dysfunctional axon-oligodendrocyte coupling in neurodegenerative diseases.
    Mot AI; Depp C; Nave KA
    Dialogues Clin Neurosci; 2018 Dec; 20(4):283-292. PubMed ID: 30936768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of oligodendroglial dysfunction in amyotrophic lateral sclerosis.
    Nonneman A; Robberecht W; Van Den Bosch L
    Neurodegener Dis Manag; 2014; 4(3):223-39. PubMed ID: 25095817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting of Disordered Proteins by Small Molecules in Neurodegenerative Diseases.
    Longhena F; Spano P; Bellucci A
    Handb Exp Pharmacol; 2018; 245():85-110. PubMed ID: 28965171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of the peripheral nervous system in synucleinopathies, tauopathies and other neurodegenerative proteinopathies of the brain.
    Wakabayashi K; Mori F; Tanji K; Orimo S; Takahashi H
    Acta Neuropathol; 2010 Jul; 120(1):1-12. PubMed ID: 20532896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concurrence of TDP-43, tau and alpha-synuclein pathology in brains of Alzheimer's disease and dementia with Lewy bodies.
    Higashi S; Iseki E; Yamamoto R; Minegishi M; Hino H; Fujisawa K; Togo T; Katsuse O; Uchikado H; Furukawa Y; Kosaka K; Arai H
    Brain Res; 2007 Dec; 1184():284-94. PubMed ID: 17963732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tau in Oligodendrocytes Takes Neurons in Sickness and in Health.
    LoPresti P
    Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30111714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mouse model of multiple system atrophy alpha-synuclein expression in oligodendrocytes causes glial and neuronal degeneration.
    Yazawa I; Giasson BI; Sasaki R; Zhang B; Joyce S; Uryu K; Trojanowski JQ; Lee VM
    Neuron; 2005 Mar; 45(6):847-59. PubMed ID: 15797547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TDP-43 proteinopathies: neurodegenerative protein misfolding diseases without amyloidosis.
    Kwong LK; Uryu K; Trojanowski JQ; Lee VM
    Neurosignals; 2008; 16(1):41-51. PubMed ID: 18097159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Histopathological and immunohistochemical study of spinal cord tissues in neurodegenerative diseases].
    Zhu M; Wang L; Liu J; Gui Q; Guo Y; Hu Y; Zhang H
    Zhonghua Bing Li Xue Za Zhi; 2015 Aug; 44(8):587-93. PubMed ID: 26705184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble alpha-synuclein.
    Tu PH; Galvin JE; Baba M; Giasson B; Tomita T; Leight S; Nakajo S; Iwatsubo T; Trojanowski JQ; Lee VM
    Ann Neurol; 1998 Sep; 44(3):415-22. PubMed ID: 9749615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Filamentous nerve cell inclusions in neurodegenerative diseases: tauopathies and alpha-synucleinopathies.
    Goedert M
    Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):1101-18. PubMed ID: 10434313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Missing in Action: Dysfunctional RNA Metabolism in Oligodendroglial Cells as a Contributor to Neurodegenerative Diseases?
    Hoch-Kraft P; Trotter J; Gonsior C
    Neurochem Res; 2020 Mar; 45(3):566-579. PubMed ID: 30843138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.